Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Immune Regulation in Pregnancy: A Matter of Perspective?

Bonney EA.

Obstet Gynecol Clin North Am. 2016 Dec;43(4):679-698. doi: 10.1016/j.ogc.2016.07.004. Epub 2016 Oct 14. Review.

PMID:
27816154
2.

Harnessing NK Cell Memory for Cancer Immunotherapy.

Fehniger TA, Cooper MA.

Trends Immunol. 2016 Dec;37(12):877-888. doi: 10.1016/j.it.2016.09.005. Epub 2016 Oct 21. Review.

PMID:
27773685
3.

Current perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptors.

Thomas LM.

Immunotargets Ther. 2015 Mar 16;4:45-53. doi: 10.2147/ITT.S61498. eCollection 2015. Review.

4.

Phenotype and functions of conventional and non-conventional NK cells.

Erick TK, Brossay L.

Curr Opin Immunol. 2016 Feb;38:67-74. doi: 10.1016/j.coi.2015.11.007. Epub 2015 Dec 17. Review.

5.

Tissue-Resident NK Cells Mediate Ischemic Kidney Injury and Are Not Depleted by Anti-Asialo-GM1 Antibody.

Victorino F, Sojka DK, Brodsky KS, McNamee EN, Masterson JC, Homann D, Yokoyama WM, Eltzschig HK, Clambey ET.

J Immunol. 2015 Nov 15;195(10):4973-85. doi: 10.4049/jimmunol.1500651. Epub 2015 Oct 9.

6.

Novel molecular mechanism for generating NK-cell fitness and memory.

Karo JM, Sun JC.

Eur J Immunol. 2015 Jul;45(7):1906-15. doi: 10.1002/eji.201445339. Epub 2015 Jun 24. Review.

7.

Analysis of GzmbCre as a Model System for Gene Deletion in the Natural Killer Cell Lineage.

Xu Y, Evaristo C, Alegre ML, Gurbuxani S, Kee BL.

PLoS One. 2015 Apr 29;10(4):e0125211. doi: 10.1371/journal.pone.0125211. eCollection 2015.

8.

Activation-specific metabolic requirements for NK Cell IFN-γ production.

Keppel MP, Saucier N, Mah AY, Vogel TP, Cooper MA.

J Immunol. 2015 Feb 15;194(4):1954-62. doi: 10.4049/jimmunol.1402099. Epub 2015 Jan 16.

9.

Multiple sclerosis and the role of immune cells.

Høglund RA, Maghazachi AA.

World J Exp Med. 2014 Aug 20;4(3):27-37. doi: 10.5493/wjem.v4.i3.27. eCollection 2014 Aug 20. Review.

10.

Beyond NK cells: the expanding universe of innate lymphoid cells.

Cella M, Miller H, Song C.

Front Immunol. 2014 Jun 16;5:282. doi: 10.3389/fimmu.2014.00282. eCollection 2014. Review.

11.

Immunological memory within the innate immune system.

Sun JC, Ugolini S, Vivier E.

EMBO J. 2014 Jun 17;33(12):1295-303. doi: 10.1002/embj.201387651. Epub 2014 Mar 27. Review.

12.

Clinical utility of natural killer cells in cancer therapy and transplantation.

Knorr DA, Bachanova V, Verneris MR, Miller JS.

Semin Immunol. 2014 Apr;26(2):161-72. doi: 10.1016/j.smim.2014.02.002. Epub 2014 Mar 5. Review.

13.

In vivo administration of a JAK3 inhibitor during acute SIV infection leads to significant increases in viral load during chronic infection.

Takahashi Y, Byrareddy SN, Albrecht C, Brameier M, Walter L, Mayne AE, Dunbar P, Russo R, Little DM, Villinger T, Khowawisetsut L, Pattanapanyasat K, Villinger F, Ansari AA.

PLoS Pathog. 2014 Mar 6;10(3):e1003929. doi: 10.1371/journal.ppat.1003929. eCollection 2014 Mar.

14.

Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model.

Geller MA, Knorr DA, Hermanson DA, Pribyl L, Bendzick L, McCullar V, Miller JS, Kaufman DS.

Cytotherapy. 2013 Oct;15(10):1297-306. doi: 10.1016/j.jcyt.2013.05.022.

15.

In vivo administration of a JAK3 inhibitor to chronically siv infected rhesus macaques leads to NK cell depletion associated with transient modest increase in viral loads.

Takahashi Y, Mayne AE, Khowawisetsut L, Pattanapanyasat K, Little D, Villinger F, Ansari AA.

PLoS One. 2013 Jul 26;8(7):e70992. doi: 10.1371/journal.pone.0070992. Print 2013.

16.

Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-α, interferon-γ and interleukin-12.

Majewska-Szczepanik M, Paust S, von Andrian UH, Askenase PW, Szczepanik M.

Immunology. 2013 Sep;140(1):98-110. doi: 10.1111/imm.12120.

17.

Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation.

Keppel MP, Yang L, Cooper MA.

J Immunol. 2013 May 1;190(9):4754-62. doi: 10.4049/jimmunol.1201742. Epub 2013 Mar 25.

18.

Controlling natural killer cell responses: integration of signals for activation and inhibition.

Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S.

Annu Rev Immunol. 2013;31:227-58. doi: 10.1146/annurev-immunol-020711-075005. Review.

19.

On the role of natural killer cells in neurodegenerative diseases.

Maghazachi AA.

Toxins (Basel). 2013 Feb 19;5(2):363-75. doi: 10.3390/toxins5020363. Review.

20.

Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRγ deficiency.

Zhang T, Scott JM, Hwang I, Kim S.

J Immunol. 2013 Feb 15;190(4):1402-6. doi: 10.4049/jimmunol.1203034. Epub 2013 Jan 23.

Supplemental Content

Support Center